Overall Status

Completed (76)

Recruiting (22)

Unknown status (19)

Terminated (15)

Active, not recruiting (8)

Not yet recruiting (8)

Withdrawn (4)

Phase

phase 3 (37)

phase 2 (21)

phase 4 (16)

n/a (7)

phase 1 (7)

phase 2/phase 3 (7)

phase 1/phase 2 (4)

early phase 1 (1)

Study Documents

CSR Synopsis (1)

Individual Participant Data Set (1)

Study overview, -data and reports, -participant list, -manuscripts and abstracts, -availability of biospecimens. (1)

Study summary, -design, -adverse event(s), -summary of participant assessments, -interventions, -medications, -demographics, -lab tests, -mechanistic assays, -files et al. (1)

Intervention Type

drug (89)

other (19)

biological (16)

device (6)

procedure (6)

diagnostic test (3)

dietary supplement (1)

Funder Type

Other (99)

Industry (36)

NIH (17)

Study Type

Interventional (100)

Observational (38)

Observational [Patient Registry] (14)

Wegener's Granulomatosis

Showing 151 - 152 of 152

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Graves´ Disease, Thyroid Associated Ophthalmopathy Trial in Odense (Methimazole, Rituximab, Immunization with various vaccines)

Completed

Graves´ Disease
Thyroid Associated Ophthalmopathy

Methimazole
+2 more

Odense, Funen, Denmark
+1 more

Oct 5, 2006

Purpura, Schoenlein-Henoch, GVHD, Anemia, Hemolytic, Autoimmune Trial in Minneapolis (anti-thymocyte globulin, cyclophosphamide,

Unknown status

Purpura, Schoenlein-Henoch
+13 more

anti-thymocyte globulin
+6 more

Minneapolis, Minnesota

Fairview University Medical Center

Jun 23, 2005